villain in this ongoing health saga. For decades, the medical community has held firm to the belief that high levels of low-density lipoprotein cholesterol (LDL-C), often dubbed "bad cholesterol," inevitably spell disaster for heart health. But what if this narrative isn't the full story? A groundbreaking new study conducted by a team of innovative researchers is turning this conventional wisdom on its head, particularly for a unique group known as lean mass hyper-responders (LMHRs). I wrote about lean mass hyper-responders in a previous post, which you can read here. Published in April 2025, this research dives into the effects of ketogenic diets on cholesterol and plaque buildup, offering fresh insights that could reshape how we assess cardiovascular risk. THis post will explore these findings and why they matter.
Read MoreThe debate over GRAS isn't just about science—it's about trust. In the U.S., where distrust in institutions runs high, the idea that companies can secretly add chemicals to food under a vague "safe" label feeds public unease. Europe's system, while not perfect, offers a counterpoint: a government-led process that, though slower, prioritizes transparency and accountability. Kennedy's push to rethink GRAS taps into this sentiment, promising a reckoning for a food industry that many Americans feel has betrayed them. Yet, the question remains whether his bold vision can navigate the political and economic realities of a nation hooked on cheap, processed goods.
Read More